Literature for evogliptin (S09.003 inhibitor)
(References are filtered for relevance to Inhibitor. To remove the filter click here. See explanation.)
-
Cho,J.M., Jang,H.W., Cheon,H., Jeong,Y.T., Kim,D.H., Lim,Y.M., Choi,S.H., Yang,E.K., Shin,C.Y., Son,M.H., Kim,S.H., Kim,H.J. and Lee,M.S.
A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing beta-cell replication and neogenesis
Diabetes Res Clin Pract91, 72-79. PubMed Europe PubMed DOI I -
Kim,H.J., Kwak,W.Y., Min,J.P., Lee,J.Y., Yoon,T.H., Kim,H.D., Shin,C.Y., Kim,M.K., Choi,S.H., Kim,H.S., Yang,E.K., Cheong,Y.H., Chae,Y.N., Park,K.J., Jang,J.M., Choi,S.J., Son,M.H., Kim,S.H., Yoo,M. and Lee,B.J.
Discovery of DA-1229: A potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
Bioorg Med Chem Lett21, 3809-3812. PubMed Europe PubMed DOI I
2011
